Mylan receives unconditional clearance on Perrigo acquisition

HERTFORDSHIRE, U.K., and PITTSBURGH — Mylan on Wednesday announced that it received unconditional clearance from the European Commission under the European Union Merger Regulation for its acquisition of Perrigo Co., an Irish international manufacturer of private-label over-the-counter pharmaceuticals.

"Today marks yet another important milestone in the process of completing our acquisition of Perrigo and serves as further affirmation of the sound industrial logic of this compelling combination,” Mylan executive chairman Robert Coury said. “We look forward to continuing on this path and completing the transaction in the coming months."

Mylan set forth its legally binding commitment to begin the offer to Perrigo on April 24.